(NOW) Stock Price prediction Lineage Cell Therapeutics Inc in 2026

Updated: 2024-11-20

Updated Stock Price Lineage Cell Therapeutics Inc plc (Lineage Cell Therapeutics Inc)

LCTX-USD Lineage Cell Therapeutics Inc - USD Dollar
0.6414000000 -0% (-0.2618)

You are interested in stocks Lineage Cell Therapeutics Inc plc and you would like to buy it, and maybe you already have it in your portfolio? If so, on this page you will find helpful information about the dynamics of the share price Lineage Cell Therapeutics Inc in 2026 How much will the share be worth Lineage Cell Therapeutics Inc in 2026?

Stock historical and prediction chart Lineage Cell Therapeutics Inc

The chart below shows the historical price fluctuation of the stock Lineage Cell Therapeutics Inc and a prediction chart for the next month. For simplicity, costs are divided into colors. Prediction prices include an optimistic prediction, a pessimistic prediction and a weighted average of the best prediction. Detailed share price values Lineage Cell Therapeutics Inc can be found in the table below.

Long-term predictions by year.

Lineage Cell Therapeutics Inc monthly stock prediction for 2026

Data Target Opt. Pes. Vol. %
Jan 0.84166 0.88732 0.78942 12.4%
Feb 0.8091 0.84007 0.77773 8.02%
Mar 0.80751 0.85158 0.75987 12.07%
Apr 0.80394 0.84285 0.76265 10.52%
May 0.77178 0.80394 0.72414 11.02%
Jun 0.76146 0.7968 0.71501 11.44%
Jul 0.83677 0.89137 0.78594 13.41%
Aug 0.82089 0.85305 0.78317 8.92%
Sep 0.8609 0.91267 0.82089 11.18%
Oct 0.79896 0.84462 0.75449 11.95%
Fox 0.80837 0.86485 0.7613 13.6%
Dec 0.81449 0.86532 0.7806 10.85%

Prediction Lineage Cell Therapeutics Inc for this year

Stock predict Lineage Cell Therapeutics Inc for 01-2026.

Uptrend prediction for this month with optimal price target at $0.84166.

Pessimistic: $0.78942.

Optimistic: $0.88732.

Stock predict Lineage Cell Therapeutics Inc for 02-2026.

Uptrend prediction for this month with optimal price target at $0.8091.

Pessimistic: $0.77773.

Optimistic: $0.84007.

Stock predict Lineage Cell Therapeutics Inc for 03-2026.

Uptrend prediction for this month with optimal price target at $0.80751.

Pessimistic: $0.75987.

Optimistic: $0.85158.

Stock predict Lineage Cell Therapeutics Inc for 04-2026.

Uptrend prediction for this month with optimal price target at $0.80394.

Pessimistic: $0.76265.

Optimistic: $0.84285.

Stock predict Lineage Cell Therapeutics Inc for 05-2026.

Uptrend prediction for this month with optimal price target at $0.77178.

Pessimistic: $0.72414.

Optimistic: $0.80394.

Info

When to take profits on stocks Lineage Cell Therapeutics Inc? When to take a loss on stocks Lineage Cell Therapeutics Inc? What are analyst prediction for the stock Lineage Cell Therapeutics Inc? What does the future hold for stocks Lineage Cell Therapeutics Inc?

We predict stock results Lineage Cell Therapeutics Inc using neural networks based on historical data about shares Lineage Cell Therapeutics Inc. In addition, the Prediction uses technical analysis tools and takes into account geopolitical factors and news from around the world.

The goal is to find an investment strategy that will provide above-average returns in all market conditions. Our predict LCTX is updated daily to help investors know whether now is a good time to buy or sell stocks LCTX.

Stock prediction results Lineage Cell Therapeutics Inc are presented in the form of charts, tables and text information divided into time intervals.

The final prices of instruments at the close of the previous trading day are a signal to revise the stock prediction Lineage Cell Therapeutics Inc. It happens once a day.

Statement

All prediction data on the website is provided for informational purposes for the use of neural predicting tools in the financial market and does not constitute a solicitation for trading, nor is it a trading signal. By using prediction data, the investor assumes all financial risk. The EURUSD.site website is not responsible for the loss of your money on the stock exchange as a result of using the information contained on the website.